Skip to main content

Members of Northern Ontario pose with the trophy after winning the gold medal game over Manitoba at the Canadian Men's Curling Championships in Edmonton, Alberta March 10, 2013. (L to R) Tom Coulterman, Brad Jacobs, Ryan Fry, E.J. Harnden, Ryan Harnden and Matt Dumontelle.

Reuters

A member of the Canadian team that won silver at the men's world curling championships has been suspended for two years after testing positive for a banned substance.

Matt Dumontelle, the alternate on Brad Jacobs's rink, tested positive for the banned substance methandienone, an anabolic steroid, in a test following the world gold-medal game.

The Canadian Curling Association said in a release that Dumontelle's positive test does not affect Canada's world championship silver, nor does it have any ramifications for the Jacobs team.

Story continues below advertisement

Dumontelle informed the CCA, World Curling Federation and the World Anti-Doping Agency that he has acknowledged the violation and has waived his right to appeal the finding.

"I was taking a workout supplement that I believed was safe; clearly, it was not and I regret that decision," Dumontelle said in a statement. "I had no intentions of trying to 'beat the system.' I was made aware by our Canadian Curling Association High Performance staff of my responsibilities to respect and follow the rules as set down by the World Anti-Doping Agency. At the end of the day I accept that it was, and is, my responsibility to make sure that I am playing by those rules."

His two-year sanction ends on May 6, 2015. Until then he is ineligible to participate in any sport that is part of the Canadian Anti-Doping Program.

Dumontelle was added to Jacobs's team following its victory at the 2013 Northern Ontario championship. He did not participate in any games at the world championship.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter